Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Globus Medical Inc (GMED)

Globus Medical Inc (GMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,922,281
  • Shares Outstanding, K 137,542
  • Annual Sales, $ 2,519 M
  • Annual Income, $ 102,980 K
  • EBIT $ 285 M
  • EBITDA $ 781 M
  • 60-Month Beta 1.19
  • Price/Sales 3.88
  • Price/Cash Flow 10.67
  • Price/Book 2.34

Options Overview Details

View History
  • Implied Volatility 34.05% ( +2.29%)
  • Historical Volatility 28.71%
  • IV Percentile 66%
  • IV Rank 46.45%
  • IV High 52.30% on 02/20/25
  • IV Low 18.22% on 11/26/24
  • Put/Call Vol Ratio 2.63
  • Today's Volume 29
  • Volume Avg (30-Day) 582
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 6,829
  • Open Int (30-Day) 8,411

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.75
  • Number of Estimates 9
  • High Estimate 0.81
  • Low Estimate 0.68
  • Prior Year 0.72
  • Growth Rate Est. (year over year) +4.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
68.88 +3.84%
on 03/13/25
85.50 -16.35%
on 02/19/25
-13.31 (-15.68%)
since 02/18/25
3-Month
68.88 +3.84%
on 03/13/25
94.93 -24.66%
on 01/30/25
-10.25 (-12.54%)
since 12/18/24
52-Week
49.33 +44.99%
on 05/01/24
94.93 -24.66%
on 01/30/25
+19.88 (+38.48%)
since 03/18/24

Most Recent Stories

More News
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

GMED : 71.67 (-0.65%)
Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

INSP : 165.28 (-0.79%)
ENOV : 38.76 (-1.10%)
GMED : 71.67 (-0.65%)
BLCO : 15.41 (+0.06%)
HAE : 65.01 (+0.32%)
Globus Medical to feature ExcelsiusFlexâ„¢ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

GMED : 71.67 (-0.65%)
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

GMED : 71.67 (-0.65%)
Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock?

Investors in Globus Medical, Inc. GMED need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 21, 2025 $67.50 Call had some of the highest implied...

GMED : 71.67 (-0.65%)
1 Mid-Cap Stock to Target This Week and 2 to Avoid

1 Mid-Cap Stock to Target This Week and 2 to Avoid

GMED : 71.67 (-0.65%)
SNA : 328.40 (-0.26%)
FFIV : 264.74 (-1.01%)
Enovis (ENOV) Q4 Earnings: What To Expect

Enovis (ENOV) Q4 Earnings: What To Expect

ENOV : 38.76 (-1.10%)
INSP : 165.28 (-0.79%)
GMED : 71.67 (-0.65%)
Globus Medical (GMED) Q4 2024 Earnings Call Transcript

GMED earnings call for the period ending December 31, 2024.

GMED : 71.67 (-0.65%)
Globus Medical: Q4 Revenue Tops Forecast

Globus Medical's robust earnings for Q4 2024 were driven by strategic acquisitions and sustained innovation.

GMED : 71.67 (-0.65%)
Globus Medical: Q4 Earnings Snapshot

Globus Medical: Q4 Earnings Snapshot

GMED : 71.67 (-0.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices,...

See More

Key Turning Points

3rd Resistance Point 75.29
2nd Resistance Point 74.03
1st Resistance Point 73.09
Last Price 71.67
1st Support Level 70.88
2nd Support Level 69.62
3rd Support Level 68.68

See More

52-Week High 94.93
Fibonacci 61.8% 77.51
Fibonacci 50% 72.13
Last Price 71.67
Fibonacci 38.2% 66.75
52-Week Low 49.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar